Results 41 to 50 of about 5,643 (237)

Emerging roles of telomeric chromatin alterations in cancer [PDF]

open access: yes, 2019
Telomeres, the nucleoprotein structures that cap the ends of eukaryotic chromosomes, play important and multiple roles in tumorigenesis. Functional telomeres need the establishment of a protective chromatin structure based on the interplay between the ...
Biroccio, Annamaria   +2 more
core   +1 more source

Microfluidic active loading of single cells enables analysis of complex clinical specimens [PDF]

open access: yes, 2013
A fundamental trade-off between flow rate and measurement precision limits performance of many single-cell detection strategies, especially for applications that require biophysical measurements from living cells within complex and low-input samples.
Malinowski, Seth W.   +7 more
core   +5 more sources

The diverse landscape of histone-mutant pediatric high-grade gliomas: A narrative review

open access: yesGlioma, 2022
Pediatric high-grade gliomas (pHGGs) are the leading cause of tumor-related death in children, with diffuse midline gliomas representing the worst prognoses.
Evan Lubanszky, Cynthia Hawkins
doaj   +1 more source

H3K27M in Gliomas Causes a One-Step Decrease in H3K27 Methylation and Reduced Spreading within the Constraints of H3K36 Methylation

open access: yesCell Reports, 2020
Summary: The discovery of H3K27M mutations in pediatric gliomas marked a new chapter in cancer epigenomics. Numerous studies have investigated the effect of this mutation on H3K27 trimethylation, but only recently have we started to realize its ...
Ashot S. Harutyunyan   +12 more
doaj   +1 more source

Pediatric posterior fossa ependymoma and metabolism: A narrative review

open access: yesGlioma, 2021
Ependymomas are a lethal central nervous system (CNS) tumor found in both adults and children. Recent efforts have focused on risk stratification by classifying the molecular variants of CNS ependymoma.
Katharine E Halligan   +6 more
doaj   +1 more source

Non-invasive methods of molecular diagnosis, clinical monitoring and approaches to the personalized therapy of diffuse midline glioma

open access: yesСибирский онкологический журнал, 2023
The purpose of the study was to summarize and analyze modern data about non-invasive methods of molecular diagnosis and approaches to the personalized therapy of diffuse midline glioma (DMG). Material and Methods.
E. V. Petersen   +8 more
doaj   +1 more source

Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomas [PDF]

open access: yes, 2014
Studies in pediatric high-grade astrocytomas (HGA) by our group and others have uncovered recurrent somatic mutations affecting highly conserved residues in histone 3 (H3) variants. One of these mutations leads to analogous p.Lys27Met (K27M) mutations in
Albrecht, Steffen   +16 more
core   +1 more source

Molecular, pathological, radiological, and immune profiling of non-brainstem pediatric high-grade glioma from the HERBY phase II randomized trial [PDF]

open access: yes, 2018
The HERBY trial was a phase II open-label, randomized, multicenter trial evaluating bevacizumab (BEV) in addition to temozolomide/radiotherapy in patients with newly diagnosed non-brainstem high-grade glioma (HGG) between the ages of 3 and 18 years.
Brouwer-Visser, Jurriaan   +30 more
core   +7 more sources

Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways [PDF]

open access: yes, 2023
UNLABELLED Patients with H3K27M-mutant diffuse midline glioma (DMG) have no proven effective therapies. ONC201 has recently demonstrated efficacy in these patients, but the mechanism behind this finding remains unknown.
Arrillaga-Romany, Isabel   +30 more
core   +1 more source

Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways

open access: yesActa Neuropathologica Communications, 2023
Globally decreased histone 3, lysine 27 tri-methylation (H3K27me3) is a hallmark of H3K27-altered diffuse midline gliomas (DMGs) and group-A posterior fossa ependymomas (PFAs).
Matthew Pun   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy